Asker Healthcare Group AB (FRA:I88) Short-Term Debt: €105 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:I88 Asker Healthcare Group AB FRA:I88
22 GF Score
Price €7.22
! 2 Warning Signs
View Full Analysis

What is Asker Healthcare Group AB Short-Term Debt?

Asker Healthcare Group AB FRA:I88 -3.52% 22 Short-Term Debt is €105 Mil as of Jun. 2026. GuruFocus rates FRA:I88 with a GF Score™ of 22/100. The stock has 2 warning signs investors should review.

Asker Healthcare Group AB's Short-Term Debt for the quarter that ended in Jun. 2026 was €105 Mil.

Asker Healthcare Group AB's quarterly Short-Term Debt increased from Dec. 2025 (€51 Mil) to Mar. 2026 (€64 Mil) and increased from Mar. 2026 (€64 Mil) to Jun. 2026 (€105 Mil).

Asker Healthcare Group AB's annual Short-Term Debt increased from Dec. 2023 (€22 Mil) to Dec. 2024 (€33 Mil) and increased from Dec. 2024 (€33 Mil) to Dec. 2025 (€51 Mil).

Asker Healthcare Group AB Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Asker Healthcare Group AB Short-Term Debt Related Terms

Asker Healthcare Group AB Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Asker Healthcare Group AB's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Asker Healthcare Group AB Short-Term Debt Chart

Asker Healthcare Group AB Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Short-Term Debt
10.46 22.44 32.51 51.18

Asker Healthcare Group AB Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 77.18 19.91 51.18 63.69 104.72
FRA:I88
22GF Score
Asker Healthcare Group AB FRA:I88
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of €105 Mil mean?
Asker Healthcare Group AB (FRA:I88) has a Short-Term Debt of €105 Mil as of Jun. 2026.
Is Asker Healthcare Group AB's Short-Term Debt too high?
Asker Healthcare Group AB's current Short-Term Debt is €105 Mil. Overall, Asker Healthcare Group AB has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Asker Healthcare Group AB's Short-Term Debt compare to MCK and COR?
Asker Healthcare Group AB's Short-Term Debt of €105 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Distribution company?
A good Short-Term Debt depends on the Medical Distribution industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Asker Healthcare Group AB's current Short-Term Debt is €105 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asker Healthcare Group AB stock overvalued right now?
Asker Healthcare Group AB (FRA:I88) has a current Short-Term Debt of €105 Mil. The current Short-Term Debt is €105 Mil. Asker Healthcare Group AB's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Asker Healthcare Group AB (FRA:I88), the current Short-Term Debt is €105 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Asker Healthcare Group AB Business Description

Other Exchanges ASKER:SwedenASKERs:UK
Address Svardvagen 3A, Danderyd, SWE, 182 33
Asker Healthcare Group AB is a provider of medical products and solutions that drive progress in the European healthcare sector. The company is engaged in building and acquiring companies to support the healthcare system to improve patient outcomes, reduce the total cost of care, and ensure a fair and sustainable value chain. The company also offers a range of value-added solutions to support its suppliers and customers in, for example, market access, efficiency, and sustainability. Company has adapted a twin engine growth strategy that combines organic and acquired growth. Geographically, the company evaluates the operations in three business areas: North, West and Central.
22GF Score

Get the complete analysis for FRA:I88

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.22
Price